Summary
#1 in Business Subscribe Email Print

You are here: Home > Health and Fitness > Medicine > Tegaserod Maleate Information

Tags

  • experienced
  • bloating
  • developing
  • stroke angina
  • companies involved

  • Links

  • Home Security - Think Like A Thief
  • Retro Decorating For The Basement
  • FOREX Education-Building a FREE Trading System For Big Profit Part 2
  • Summary - Tegaserod Maleate Information

    Zelnorm Recall Update: Zelnorm has recently been recalled by the U.S. Food & Drug Administration due to its link to serious, life-threatening side effects. These side eff
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    ects include heart attack, stroke, angina pectoris, heart attack, stroke, angina pectoris, Intestinal Ischemia, Colonic Ischemia and Ischemic Colitis. What is Zelnorm?

    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    egaserod maleate, more commonly known as the prescription drug Zelnorm, is marketed by Novartis Pharmaceuticals. The United States Food and Drug Administration approved it in July of 2004
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    Zelnorm is intended for the short-term treatment of irritable bowel syndrome (IBS) in women. IBS is a syndrome that affects the function of the large intestine and colon. The drug is mai
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    ly meant to relieve severe, chronic constipation that is a main symptom of IBS. Zelnorm has never been tested on men and therefore not prescribed to males.

    The drug is not a cure for IBS
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    but only a treatment. It is believed that Zelnorm provides benefits for most patients that suffer from irritable bowel syndrome and constipation because it increases the movement of fec
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    l matter through the intestinal system. The drug is effective in relieving constipation (hard stools or difficulty passing stools) as it increases serotonin within the intestines. The inc
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    rease in serotonin in turn increases the movement of stool through the bowels. For many patients that have used the drug, they have experienced a reduction in pain, discomfort, bloating,
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    nd constipation.

    How to Use Zelnorm Because Zelnorm is a prescription drug, it is important to take it only as directed by a licensed physician. Never take a drug if you
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    are unsure or do not fully understand the instructions. Your doctor or pharmacist will always be happy to explain them to you. Always be sure to take Zelnorm with a full glass of water an
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    on an empty stomach. Typically, the regimen requires that the drug be taken twice a day. It is important to understand that Zelnorm is not a cure for irritable bowel syndrome, but is onl
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    a treatment. If the regimen is halted, symptoms of IBS may return within two weeks. Always remember that Zelnorm does not reduce the symptoms of irritable bowel syndrome in every person
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    It may relieve all, just some, or none of the pain, bloating, and constipation commonly associated with IBS. If, after about a month, there is no improvement, Zelnorm may not be the best
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    treatment and should be stopped with the consultation of a physician.

    Zelnorm Side Effects As with any prescription or over the counter medication, there are tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    tp://www.schmidtandclark.com/Zelnorm/" target="_blank">side effects associated with the use of Zelnorm. The most commonly experienced side effects include, but are not limited to, hea
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    aches, abdominal pain, diarrhea, nausea, and dizziness. More serious side effects include heart attack, stroke, angina pectoris, Intestinal Ischemia, Colonic Ischemia and Ischemic Colitis
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    Upon prescribing Zelnorm, the physician will review and explain the side effects to the patient.

    Additionally, any patient that is prone to excessive diarrhea, bad kidney function, live
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    disease, bowel obstructions, gallbladder disease, or abdominal adhesions should not take Zelnorm as treatment for irritable bowel syndrome. The drug may exacerbate these preexisting cond
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    tions. Zelnorm is intended for short-term treatment of irritable bowel syndrome only and is not recommended for long-term use. Physicians suggest that the drug be used only for several w
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    eks or months at a time. Most often, the effects of the drug wear off after extended use. *This article does not constitute medical advice and is for informational purposes only.

    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.summary.org.ua/article/251739/summary-Tegaserod-Maleate-Information.html">Tegaserod Maleate Information</a>

    BB link (for phorums):
    [url=http://www.summary.org.ua/article/251739/summary-Tegaserod-Maleate-Information.html]Tegaserod Maleate Information[/url]

    Related Articles:

    Square Peg in a Round Hole - Being a Creative Artist in the Corporate World

    Advanced Article Writing Techniques: Stop Pushing Off Your Keywords

    Help Your Significant Other Part II

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com